
Novavax Outlines Path After FDA Delay
Novavax moved to reassure investors on Thursday after U.S. regulators delayed full approval of its COVID-19 vaccine, saying it sees a clear route to address the Food and Drug Administration’s

Novavax moved to reassure investors on Thursday after U.S. regulators delayed full approval of its COVID-19 vaccine, saying it sees a clear route to address the Food and Drug Administration’s

TechCrunch is warning companies about a new wave of impostors posing as its reporters and event staff, attempting to extract information and money from targets. The outlet says scammers are
Another week, another wave of AI releases and drama. The noise is getting louder, but the signal is clear. My view: the latest model bumps matter less for casual users

A new tech entrant is pitching a simple idea to a complex problem: link systems quickly and tailor them without heavy coding. The company unveiled a platform positioned to help

Apple signaled a busy stretch of hardware news, with CEO Tim Cook saying a “big week” of product announcements is imminent. The Cupertino company is preparing to reveal a budget-friendly

Nearly a quarter century after the September 11 attacks, the rebuild of Lower Manhattan’s World Trade Center site is approaching its final phase. The next step is the long-delayed 2

Before the opening bell, sharp swings in several U.S. stocks hinted at a busy session ahead, as traders reacted to fresh headlines and thin liquidity. Early indications pointed to active

More than one in ten U.S. teenagers now turn to artificial intelligence tools for emotional support or advice, according to new findings from the Pew Research Center. The survey also

Under mounting criticism, Capgemini said it is reassessing its part in a covert monitoring effort aimed at immigrants in the United States. The Paris-based technology and consulting firm confirmed it